Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. El-Shakmak
ACE-inhibitors but Not Endothelin Receptor Blockers Prevent Podocyte Loss in Early Diabetic Nephropathy
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Prevention of Dementia by ACE Inhibitors and Angiotensin Receptor Blockers - Potential but Not Proven
International Journal of Clinical Practice
Medicine
Does the Use of ACE Inhibitors or Angiotensin Receptor Blockers Affect Bone Loss in Older Men?
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Loss of PTEN Promotes Podocyte Cytoskeletal Rearrangement, Aggravating Diabetic Nephropathy
Journal of Pathology
Forensic Medicine
Pathology
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
ACE Inhibition and Diabetic Nephropathy
BMJ
Glomerular Mesangial Cell and Podocyte Injuries in Diabetic Nephropathy
Nephrology
Medicine
Nephrology
Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?
Journal of Hypertension- Open Access
ACE Inhibition and Diabetic Nephropathy: Author's Reply
BMJ
Interaction of Spironolactone With ACE Inhibitors or Angiotensin Receptor Blockers: Analysis of 44 Cases
BMJ